Search Results for "hpv"
Peer reviewed critique of Mercks reckless and immoral marketing strategy for gardisil.
Comments in response to: “Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.”
Researchers assert that bivalent HPV vaccination in Scotland has been “highly effective” in reducing pre-malignant cervical disease, but have failed to discuss serious adverse events following HPV vaccination or other secular trends that could provide an explanation for the declines.
Controversy about alleged adverse events following immunization (AEFI) with HPV vaccine have led to extensive reductions in vaccine acceptance. By making comparisons, authors conclude that any causal links between HPV vaccine and AEFIs, as well as the underlying molecular basis for the links will be revealed and can provide an objective basis for evaluating HPV vaccine safety and for identifying biomarkers for individuals at risk of developing AEFI with HPV vaccination.
Bioinformatics and epidemiological evidence link yeast protein containing HPV and Hepatitis B vaccines to numerous autoimmune disorders such as vitiligo, narcolepsy, hypothyroidism, systemic lupus erythematosus and rheumatoid arthritis
Yeast proteins in the human papillomavirus (HPV) and hepatitis B vaccines—in combination with powerful adjuvants—can give rise to autoimmune reactions, and “non-target” proteins in other vaccines can do the same.
Data restrictions imposed by vaccine manufacturers and regulators inhibit independent researchers’ ability to conduct comprehensive and accurate assessments of HPV vaccine safety.
Severe, long-term disability and even death can occur in a subset of individuals vulnerable to “HPV vaccination syndrome.”
HPV-vaccinated women, in some settings, are less likely to get routine cervical cancer screening, which is necessary to reduce population incidence of cervical cancer.
Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial
Serious adverse events observed in pre-licensure trials of Gardasil-9 cast doubts on HPV vaccine safety, but the trial investigators described the adverse events as not vaccine-related.
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil
Israeli, Canadian and Colombian scientists show that the Gardasil vaccine triggers brain inflammation and autoimmunity in mice.
Vaccination with bovine, chick, yeast antigens synthesizes cross-reactive antibodies targeting human acetylcholine receptor and MuSK protein to cause Myasthenia Gravis: Confirmed by natural experiment (VAERS data), bioinformatics, case reports, animal experiments and titer study
Animal protein containing vaccines cause autoimmune diseases even when
the vaccine does not contain an adjuvant. Adjuvanted vaccines only make the problem worse.
Vaccines interact to cause autoimmune diseases.
Tags: autoimmune disorders, Graves’ disease, Hepatitis B, HPV VACCINE, Influenza, MuSK, myasthenia gravis, myasthenic syndrome, residual proteins, Type 1 Diabetes, vaccine, Vaccine adverse event reporting system-VAERS
Autoantibodies against Autonomic Nerve Receptors in Adolescent Japanese Girls after Immunization with Human Papillomavirus Vaccine
This preliminary study provides evidence that post-vaccination abnormal autoimmunity plays an important role in the development of unique symptoms after HPV vaccination.
Comment on: Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Gardasil clinical trial and post-marketing data should raise a red flag about HPV vaccine safety.
A lowered probability of pregnancy in females in the USA aged 25–29 who received a human papillomavirus vaccine injection
Women vaccinated for HPV have a lower probability of conceiving.
French Professors demand immediate stop to Al use in vaccines and medications like antacids, as evidence shows that it poses a deadly danger to humans.
Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study
The evidence does not support HPV vaccine effectiveness in women in their mid- to late 20s.
Discrepancies in how countries define and evaluate difficult-to-diagnose vaccine complications may affect their conclusions about HPV vaccine safety.
Vaccination can trigger a series of cascading events that disturbs the balance between “protective immunity” and “destructive inflammation.”
Israeli and Italian scientists warn that vaccine adjuvants (aluminum) are causing a wide-range of autoimmune conditions, including Sjogren’s Syndrome.
Adolescent premature ovarian insufficiency following human papillomavirus vaccination: A case series seen in general practice
FDA’s instruction to health providers that “there is no biologically plausible way in which HPV vaccine could cause infertility” is not science-based and compromises safety monitoring by undermining reporting efficiency, safety signaling and informed consent.
Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants
Israeli, Italian, and Canadian researchers tie HPV vaccine to primary ovarian failure.